Physician

Allan Julian Beall Sacasa, M.D.

According to 2025 Medicare claims, Allan Sacasa, M.D. (NPI: 1609173426) practices interventional cardiology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is ADVOCATE HEALTH AND HOSPITALS CORPORATION (NPI: 1700824455; TIN: 362169147) and primary practice location at 60657-4414. Sacasa is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033) and Accountable Care Organization of Advocate Aurora Health, LLC (ACO ID: D0260), participating under both the MSSP and REACH models.

Sacasa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 471 traditional Medicare patients, billed 1,287 HCPCS/CPT codes, and received $136,907 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 4,491 prescription claims across 707 beneficiaries totaling $750,608 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 9 records totaling $348. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $52,098 and ending at $136,907. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $12,493 to $750,608. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	443	870	$52,098
2016	1,086	2,310	$149,434
2017	688	1,580	$114,247
2018	580	1,309	$94,168
2019	517	1,324	$112,316
2020	326	818	$77,596
2021	402	1,057	$108,134
2022	370	790	$86,142
2023	432	988	$92,175
2024	471	1,287	$136,907

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	59	182	$12,493
2016	134	622	$29,483
2017	212	947	$37,582
2018	325	1,666	$123,066
2019	400	2,091	$210,218
2020	438	2,605	$316,011
2021	488	3,236	$538,480
2022	576	3,967	$659,377
2023	624	4,443	$755,129
2024	707	4,491	$750,608

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	73	73	$156
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	128	134	$132
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	91	92	$10
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	66	70	$10
36415	Insertion of needle into vein for collection of blood sample	67	77	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	209	13,245	$256,257
Entresto	Sacubitril/Valsartan	41	3,180	$70,685
Xarelto	Rivaroxaban	52	2,820	$52,846
Repatha Sureclick	Evolocumab	69	2,492	$48,141
Brilinta	Ticagrelor	52	3,181	$46,618

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$348	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Allan Julian Beall Sacasa, M.D.?

Tedicare shows public-source Medicare data for Allan Julian Beall Sacasa, M.D. (NPI 1609173426), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Allan Julian Beall Sacasa, M.D. have ACO affiliation data?

Allan Julian Beall Sacasa, M.D. is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033) and Accountable Care Organization of Advocate Aurora Health, LLC (REACH, ACO ID D0260).

What billing organization is linked to Allan Julian Beall Sacasa, M.D.?

Allan Julian Beall Sacasa, M.D. is linked to ADVOCATE HEALTH AND HOSPITALS CORPORATION (billing NPI 1700824455) in the available physician profile data.

Does Allan Julian Beall Sacasa, M.D. have Open Payments data?

Allan Julian Beall Sacasa, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.